Cesare Berra

1.5k total citations · 1 hit paper
40 papers, 860 citations indexed

About

Cesare Berra is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Cesare Berra has authored 40 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Cesare Berra's work include Diabetes Treatment and Management (20 papers), Diabetes Management and Research (12 papers) and Metabolism, Diabetes, and Cancer (11 papers). Cesare Berra is often cited by papers focused on Diabetes Treatment and Management (20 papers), Diabetes Management and Research (12 papers) and Metabolism, Diabetes, and Cancer (11 papers). Cesare Berra collaborates with scholars based in Italy, United States and Denmark. Cesare Berra's co-authors include Paolo Fiorina, Maria Elena Lunati, Ida Pastore, Cristian Loretelli, Francesca D’Addio, Moufida Ben Nasr, Elisa Lazzaroni, Gianvincenzo Zuccotti, Laura Montefusco and Franco Folli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Cesare Berra

34 papers receiving 845 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists

2022 217 citations Giulia Bendotti, Laura Montefusco et al. Pharmacological Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cesare Berra Italy	16	530	249	197	138	116	40	860
Francis C. C. Chow Hong Kong	14	765 1.4×	369 1.5×	247 1.3×	118 0.9×	117 1.0×	28	1.1k
Francis Chun Chung Chow Hong Kong	11	661 1.2×	296 1.2×	187 0.9×	96 0.7×	115 1.0×	16	855
Jun‐Sing Wang Taiwan	17	411 0.8×	226 0.9×	152 0.8×	138 1.0×	134 1.2×	93	1.0k
Ehtasham Ahmad United Kingdom	8	365 0.7×	252 1.0×	138 0.7×	244 1.8×	119 1.0×	20	834
Sanbao Chai China	17	582 1.1×	289 1.2×	212 1.1×	135 1.0×	171 1.5×	49	935
Alexandra Katsimardou Greece	11	403 0.8×	231 0.9×	137 0.7×	150 1.1×	157 1.4×	40	982
Oliver Götze Germany	10	295 0.6×	222 0.9×	186 0.9×	109 0.8×	68 0.6×	28	802
Päivi M. Paldánius Switzerland	15	772 1.5×	373 1.5×	224 1.1×	172 1.2×	128 1.1×	39	1.3k
Athanasios Raptis Greece	15	323 0.6×	256 1.0×	103 0.5×	140 1.0×	99 0.9×	39	1.0k
Ching‐Chu Chen Taiwan	16	305 0.6×	224 0.9×	124 0.6×	136 1.0×	149 1.3×	50	812

Countries citing papers authored by Cesare Berra

Since Specialization

Citations

This map shows the geographic impact of Cesare Berra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesare Berra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesare Berra more than expected).

Fields of papers citing papers by Cesare Berra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesare Berra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesare Berra. The network helps show where Cesare Berra may publish in the future.

Co-authorship network of co-authors of Cesare Berra

This figure shows the co-authorship network connecting the top 25 collaborators of Cesare Berra. A scholar is included among the top collaborators of Cesare Berra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesare Berra. Cesare Berra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lunati, Maria Elena, Davide Paolo Bernasconi, Olga Disoteo, et al.. (2026). The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults. The Journal of Clinical Endocrinology & Metabolism.

Sala, Lucia La, Valentina Carlini, E Trabucchi, et al.. (2025). The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility. Journal of Advanced Research. 1 indexed citations

Zuccotti, Gianvincenzo, et al.. (2025). Vital Sign and Biochemical Data Collection Using Non-contact Photoplethysmography and the Comestai Mobile Health App: Protocol for an Observational Study. JMIR Research Protocols. 14. e65229–e65229.

Pellegrini, Valeria, Rosalba La Grotta, Angelica Giuliani, et al.. (2024). Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment. Cells. 13(19). 1662–1662. 26 indexed citations

Berra, Cesare, Roberto Manfrini, Francesco Bifari, et al.. (2024). Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE−2 study. Pharmacological Research. 210. 107517–107517. 4 indexed citations

Prattichizzo, Francesco, Valentina Veronesi, Marta Rigoni, et al.. (2024). Body weight variability as a predictor of cardiovascular outcomes in type 1 diabetes: A nationwide cohort study. Diabetes Obesity and Metabolism. 27(2). 490–500. 1 indexed citations

Folli, Franco, Giovanna Finzi, Roberto Manfrini, et al.. (2023). Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets. American Journal of Physiology-Endocrinology and Metabolism. 325(5). E595–E609. 13 indexed citations

Berra, Cesare, Roberto Manfrini, Marco Mirani, et al.. (2023). AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus. Acta Diabetologica. 60(9). 1257–1266. 6 indexed citations

Napoli, Raffaele, Cesare Berra, Andrei‐Mircea Catarig, et al.. (2023). Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the SURE Italy observational study. Diabetes Obesity and Metabolism. 25(6). 1658–1667. 24 indexed citations

10.

Bendotti, Giulia, Laura Montefusco, Maria Elena Lunati, et al.. (2022). The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists. Pharmacological Research. 182. 106320–106320. 217 indexed citations breakdown →

11.

Grotta, Rosalba La, Paola de Candia, Olivieri Fabiola, et al.. (2022). Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin. Cellular and Molecular Life Sciences. 79(5). 273–273. 81 indexed citations

12.

Mancini, Mario, Francesca Pecori Giraldi, Michela Salvioni, et al.. (2021). Obesity Is Strongly Associated With Low Testosterone and Reduced Penis Growth During Development. The Journal of Clinical Endocrinology & Metabolism. 106(11). 3151–3159. 11 indexed citations

13.

Berra, Cesare, et al.. (2021). The role of patient preferences in adherence to treatment in chronic disease: a narrative review. SHILAP Revista de lepidopterología. 15. 13–20. 44 indexed citations

14.

Ponzani, Paola, Cesare Berra, Paola Sindaco, et al.. (2019). Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety. Diabetes Therapy. 11(1). 97–105. 5 indexed citations

15.

Bifari, Francesco, Roberto Manfrini, Michele Dei, et al.. (2018). Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Pharmacological Research. 137. 219–229. 54 indexed citations

16.

Simioni, Natalino, Cesare Berra, Massimo Boemi, et al.. (2018). Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting. Acta Diabetologica. 55(6). 557–568. 18 indexed citations

17.

Mirani, Marco, et al.. (2018). Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort. Pharmacological Research. 137. 270–279. 16 indexed citations

18.

Aghemo, Alessio, Cesare Berra, & Massimo Colombo. (2018). Managing Patients With Nonalcoholic Fatty Liver Disease: Is It Really Only About Fibrosis?. Gastroenterology. 155(3). 926–928. 1 indexed citations

19.

Mirani, Marco, Cesare Berra, Silvia Finazzi, et al.. (2010). Inter-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Patients on Hemodialysis. Diabetes Technology & Therapeutics. 12(10). 749–753. 46 indexed citations

20.

Torta, Riccardo, et al.. (2001). Therapeutic aspects of depression in the elderly. Archives of Gerontology and Geriatrics. 33. 401–412.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact